[Rosuvastatin has no effect on clinical outcomes in patients with heart failure. Results of the GISSI-HF trial]. [electronic resource]
Producer: 20090630Description: 64-5 p. digitalISSN:- 0022-9040
- Fluorobenzenes -- therapeutic use
- Heart Failure -- drug therapy
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Pyrimidines -- therapeutic use
- Randomized Controlled Trials as Topic
- Rosuvastatin Calcium
- Stroke Volume -- drug effects
- Sulfonamides -- therapeutic use
- Survival Rate -- trends
- Treatment Outcome
No physical items for this record
Publication Type: News
There are no comments on this title.
Log in to your account to post a comment.